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Abstract
The present study investigates the antimalarial activity of 13 medicinal plants used in traditional medicine in S. Tome´ and Prı´ncipe
(STP) islands in the Gulf of Guinea, aiming at identifying the most effective plants for further research. Fieldwork was carried out
with the collaboration of 37 traditional healers from both islands, during an ethnobotanical study, which was conducted from 1993
to 1999. Our results indicate that the traditional healers in STP use several medicinal plants against fever and/or ‘malaria’ which
reveal strong antiparasitic activity in vitro: four of the plant extracts have evident antiplasmodial activity against chloroquine
resistant Plasmodium falciparum , with IC50 values B/10 mg/ml, and also revealed hepatic schizontocidal activity (B/5/35 mg/ml). In
vivo, the extracts caused partial reduction of Plasmodium berghei parasitaemia in mice. # 2002 Elsevier Science Ireland Ltd. All
rights reserved.
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1. Introduction
Malaria is the most important parasitic disease in
tropical areas. In the last decades resistance to several
antimalarials became widely disseminated, while the cost
of effective treatment is prohibitive for the large
majority of the populations in these areas. There is an
urgent need for new chemotherapeutic compounds,
which are easy to administer and store, and which are
of low cost. One possible source for such affordable
treatments lies in the use of traditional herbal remedies.
The use of plants for the treatment of malaria extends
over at least three continents, including several countries
in Africa, in the Americas and in Asia (Phillipson et al.,
1987). However, few data are available to assess the
extent to which these plant remedies are used in the
health care systems of tropical countries. The recogni-
tion and validation of traditional medical practices and
the search for plant-derived drugs could lead to new
strategies in malaria control. Since many modern drugs
such as quinine and artemisinin originate from plants, it
is essential that other medicinal plants which have
folklore reputation for antimalarial properties are
investigated, in order to establish their safety and
efficacy, and to determine their potential as sources of
new antimalarial drugs (Gessler et al., 1994).
To overcome some of the most common problems in
this field, such as the identification of plant material and
the variability of the chemical content of the locally used
plant remedies, we evaluated, following normal proce-
dures, some of the plants used by the traditional healers
in the Gulf of Guinea islands of S. Tome´ and Prı´ncipe
(STP), where two-thirds of the population live in regions
where endemic malaria occurs (Loureiro et al., 1996).
Data on about 350 different species was collected by
personal contact with local traditional healers during an
ethnobotanical survey of medicinal plants, conducted
from 1993 to 1999, in both islands. The present study
investigates the antimalarial activity and toxicity of 13
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medicinal plants that are used by traditional healers in
STP for the treatment of malaria and fever.
2. Methodology
2.1. Ethnobotanical survey
In this paper, we present ethnobotanical data on
medicinal plants that are used to treat malaria and other
fevers, based on first-hand information collected by
personal contact with traditional healers, ordinary
villagers (old people), as well as through personal
observations of applications of the herbal remedies
administered by traditional healers.
Local traditional healers called ‘curandeiros’ were the
main guides of the study. ‘Fitchice´los’, are another
group, which uses witchcraft, and their treatments are
based mainly on magical rites, sometimes combined
with plant therapy; only a few ‘fitchice´los’ were con-
sulted during the study. Old people, who had knowledge
of the curative property of plants, were the second most
important group with whom the research team has
worked. It is also important to emphasize the impor-
tance of the ‘mother of family’ (mother, grand-mother),
who is capable of treating the every day (less significant)
ailments of her family using the medicinal plants grown
in her own backyard.
The field team worked with 37 traditional healers on
both islands, covering all the districts: A´gua Grande,
Me´zochi, Cantagalo, Caue´, Lobata and Lemba´ (S.
Tome´), and Pague´ (Prı´ncipe). Information was collected
through informal interviews, which were recorded on
tape and filmed during fieldwork with traditional
healers. The gathering and recording of information
were repeated several times, in different periods of the
year. Each individual was asked about the plants used
for medicinal purposes in their area, and for each plant
the following descriptors were recorded: vernacular
names, part of plant used, the mode of preparation,
the form of administration of the remedies, the diseases
and also the symptoms for which they were recom-
mended.
2.2. Collection of plants
Thirteen plant species were selected based on ethno-
medical use in the islands, on data from literature
surveys (Makinde et al., 1994; Koshimizu, 1992) and
on chemical and biological characteristics of related
species.
These plants were collected under the guidance of the
healers. Prior to collection the team always obtained
permission from the healers, village chiefs, landowners
and government (Ministry of Health). Voucher speci-
mens of these medicinal plants, with specimen data
including vernacular name, voucher number, collecting
locality and date of collection are deposited at the
Herbarium of the Instituto Botaˆnico, Coimbra Univer-
sity (COI) (Table 1).
2.3. Extract preparation
Dried material was powdered and extracted with
ethanol 70%, concentrated by rotary vacuum evapora-
tion and lyophilized (CEE-crude ethanol extracts).
Fresh material was only used for plants n8 7 and 13,
which were initially homogenized, followed by same
procedure. To obtain a preliminary separation of
bioactive constituent groups, the CEE of each plant
Table 1
Medicinal plants traditionally used for malaria and fevers
Number Botanical name/family Local name Local of collection Voucher No. (COI) Plant part used
1 Struchium sparganophorum (L.) Kuntze/Asteraceae Liboˆ d’aua A´gua Crioula MM 125 Leaves
2 Vernonia amygdalina Del.a/Asteraceae Liboˆ Mucambu Born Jesus MM 114 Leaves
3 Vernonia amygdalina Del.a/Asteraceae Liboˆ Que´ Morro Quinas MM 21 Leaves
4 Ageratum conyzoides L./Asteraceae Fia´ Male´ Rio Ave MM 28 Aerial P.
5 Cinchona succirubra Pav./Rubiaceae Quina Diogo Vaz MM 25 Bark
6 Aloe humilis L./Liliaceae A´liba Babosa Blu-Blu MM 354 Leaf sap
7 Tithonia diversifolia (Hmsl.) A. Gray/Asteraceae Girassol Monte Cafe´ MM 625 Aerial P.
8 Cedrela odorata L./Meliaceae Cidrela Ubua Coconja MM 321 Bark
9 Premna angolensis Curke/Verbenaceae Po´ Ama Apaga-Foguinho MM 619 Bark
10 Pycnanthus angolensis (Welw. Ward)/Myristicaceae Po´ Casson Fraternidade MM 426 Bark
11a Morinda lucida Benth. (bark)/Rubiaceae Gligoˆ Diogo Vaz MM 26 Bark
11b Morinda lucida Benth. (leaves)/Rubiaceae Gligoˆ Diogo Vaz MM 26 Leaves
12 Cestrum laevigatum Schlecht.var. puberuleum
Sendtn./Solanaceae
Coedano Guadalupe MM 102 Leaves
13 Canna bidentata L./Canaceae Salaconta Morro Quinas MM 14 Roots
a Different chemotypes of the same species, but locally distinguished by the traditional healers.
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was dissolved in methanol and water 1:2 (MW) and
subsequently partitioned between petroleum ether (PE),
dichloromethane (DM) and ethyl acetate (EA); all the
resulting fractions were lyophilized after concentration
by rotary vacuum evaporation. Samples were frozen at
/20 8C.
2.4. Determination of in vitro antiplasmodial activity in
plant extracts
2.4.1. Blood stage assays
To test the antiplasmodial activity of plant extracts we
used the susceptibility microassay technique (Desjardins
et al., 1979; Carvalho and Krettli, 1991). Two strains of
Plasmodium falciparum: 3D7/chloroquine sensitive
clone of isolate NF54, and Dd2/chloroquine resistant
clone from the W2-MEF line (Wellems et al., 1990) were
continuously maintained in culture, by the method of
Trager and Jensen (1976) and used in these assays.
Each CEE and fraction were dissolved in ethanol and
diluted with RPMI 1640 culture medium, with 10%
human serum, to prepare stock solutions (5 mg/ml with
1% ethanol). These solutions were sterilized through
membrane filters of 0.45 mm and used to prepare a series
of concentrations of 500, 250, 100, 50, 25,10, 5 and 1 mg/
ml. Chloroquine was used as control and negative
controls were prepared with the culture medium and
0.1% ethanol content.
For the microtest, 90 ml aliquots of the control and
test solutions were added to all of the wells of the flat-
bottomed microtitre plate, and aliquots of 10 ml of a
50% (v/v) suspension of parasitized erythrocytes in
culture medium (0.5/1.0% parasitaemia) were added
to all test wells. Three duplicate assays were carried out
per parasite line; microtitre plates were placed in a
candle jar with a gas mixture of 3% CO2/5% O2/92%
N2, and incubated at 37 8C for 24 h; thick films were
prepared when control wells, stained with Giemsa,
showed schizont formation, parasitaemias were estab-
lished by optical microscopy. The results are expressed
as percentage of growth inhibition. The concentration,
which inhibited growth by 50% (IC50) in comparison to
control wells, was estimated by linear interpolation
between drug concentrations values (Hills et al., 1986)
(Table 2).
2.4.2. Hepatic stage assays
These assays evaluate the inhibition of development
of the liver stage parasite, as well as the toxicity of the
plant extracts to the hepatic host cells.
2.4.2.1. Viability assays (hepatotoxicity test). An in
vitro culture of HepG2 A16 hepatic cells was mixed
with William’s E culture medium (25/103 cells/200
microlitre) and this volume was added to all of the 96 ml
plate wells, and incubated at 37 8C in an enriched CO2
environment for 18/24 h.
Plant extracts were dissolved with ethanol and diluted
with William’s E culture medium to obtain six concen-
trations: 500, 250, 100, 50, 25 and 10 mg/ml, with a
maximum of 0.1% in ethanol content. Primaquine was
used as positive control, and the negative controls were
prepared with culture medium and 0.1% ethanol.
After the incubation period the HepG2 cells were
adherent to the wells and the supernatant liquid was
removed and substituted by 200 ml of the different
extract concentrations and controls. The plate was
incubated during 24 h more, in the same conditions as
Table 2
Antimalarial activity of plant extracts against P. falciparum (Dd2) in vitro
Number Plant species IC50, median values (mg/ml)
CEE PE DM EA MW
1 Struchium sparganophorum 180 B10 100 100 240
2 Vernonia amygdalina a 120 170 235 500 n.d.
3 Vernonia amygdalina b 340 200 80 10 n.d.
4 Ageratum conyzoides 150 110 55 220 n.d.
5 Cinchona succirubra B10 B10 B10 B10 B10
6 Aloe humilis 260 150 150 25 500
7 Tithonia diversifolia 15 B10 B10 140 500
8 Cedrela odorata 190 110 50 n.d. n.d.
9 Premna angolensis 180 250 250 250 n.d.
10 Pycnanthus angolensis B5 100 100 100 n.d.
11a Morinda lucida (bark ) B10 50 50 100 500
11b Morinda lucida (leaves ) 10 130 60 500 125
12 Cestrum laevigatum 100 100 50 150 135
13 Canna bidentata 500 130 25 245 500
CEE, crude ethanolic extracts; PE, petroleum ether fraction, DM, dichloromethane fraction; EA, ethyl acetate fraction; MW, remanescent methanol
and water fraction; n.d., not determined. IC50 (chloroquine), 0.094 mg/ml.
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described before; after this period, the supernatant
liquid was removed again and substituted by 200 ml
more of the same extract or control solutions. At the end
of the incubation period, 20 ml of MTT solution (5 mg/
ml in RPMI 1640, without phenol red) was added to
each well, after what the plate was incubated for more 3
h in the same conditions. The supernatant was then
removed and 200 ml of acidified isopropanol added to
the wells. These assays were performed in triplicate, to
determine the maximum non-toxical concentration to
the hepatic cells (Sinden et al., 1990).
Results were obtained by ELISA with a filter of 570
nm and a background of 630 nm and the minimum
lethal dose (MLD) was determined for each extract
(concentration that inhibits 30% of cell growth).
2.4.2.2. Antimalarial exoerythrocytic schizontocidal as-
say. Female Balb/C mice were infected with Plasmodium
berghei ANKA malaria parasites; 5/8 days later, while
exhibiting gametocytes, these mice were submitted to
insectory maintained Anopheles stephensi females for an
infectious blood meal, and 14/18 days later sporozoites
were collected from dissected mosquito salivary glands
and used to infect Hep G2 A16 cells (Trager and Jensen,
1976; Hills et al., 1986) in in-vitro cultures (Calvo-Calle
et al., 1994; Hollingdale et al., 1983; Sinden, 1991;
Denizot and Lang, 1986).
A cell suspension of 40/103 cells/300 ml in culture
medium was added to each labtek microplate well and
incubated, as described above, for 24 h. The supernatant
liquid was replaced by a sporozoite suspension of 100/
103/100 ml, and the microplate was incubated again for 3
h.
For each plant extract and fraction, 300 ml of the
concentration which exhibited 70% of cell growth in the
viability assay (MLD), as well as its immediate lower
concentration, were now tested in triplicate in the in
vitro culture of the exoerythrocytic stage of P. berghei in
HepG2 cells (Hollingdale et al., 1983; Millet et al.,
1986). Results were obtained through immunofluores-
cence assay (Danforth et al., 1978). The fixed cell
cultures were incubated with 100 ml of a mixture of
monoclonal antibody i72 (20 ml), stage-specific immune
serum (20 ml) and phosphate-buffered-saline (PBS) (960
ml), for 30 min at 37 8C, in a humid chamber. The wells
were washed with 400 ml PBS, and the cultures were
reacted with 100 ml of a mixture of GAMIg/FITC (10
ml), blue Evans (50 ml) and PBS (940 ml), for another 30
min, in the same conditions. After washing with PBS the
slides were prepared with a solution 1:1 glycerol/PBS
and examined by immunofluorescence microscope.
Tests were repeated in two separate experiments. The
concentration, which inhibited the development of
hepatic schizonts growth by 50% (IC50), in comparison
to control wells, was estimated by linear interpolation
between drug concentrations values and negative con-
trols (Table 3).
2.5. Determination of in vivo antimalarial activity in
plant extracts
For in vivo tests the ‘Four-day suppressive test’
(O’Neill et al., 1987) was used, with female Balb/C
mice (6-week old; 9/20 g weigh) infected by intraper-
itoneal innoculations of 107 erythrocytes parasitised
with P. berghei ANKA malaria parasite.
Plant extracts and fractions were solubilized or
suspended in ethanol at the maximum proportion of
1% (v/v) in distilled water, tested in two concentrations
(500 and 1000 mg/kg body weight), administered daily,
orally, during 4 days, to infected mice (in groups of five
animals). Blood films were taken on the fourth day (96 h
after the first dose), Giemsa stained and examined
microscopically and the level of parasitaemia was
calculated. Extract activity was determinate by percent
reduction of parasitaemia in treated groups compared
with untreated infected mice. The statistical analysis was
based on Student’s t-test transformed in P -values (P/
0.05 is not significant; PB/0.05 is significant). Controls
with local Cinchona extracts, at the same doses, were
included. Survival studies were also carried out with
these animals.
3. Results and discussion
From the group of studied plants only three species
(Cedrela odorata , Morinda lucida and Vernonia amyg-
dalina) have been previously investigated for their
antimalarial activity (MacKinnon et al., 1997; Tona et
al., 1999; Masaba, 2000), however, this is the first time
that the hepatic schizontocidal activity of these plants
was determined. To our knowledge, this is the first time
that Ageratum conyzoides , Aloe humilis , Canna biden-
tata , Cestrum laevigatum , Premna angolensis , Pyc-
nanthus angolensis , Struchium sparganophorum and
Tithonia diversifolia are being assessed for their anti-
plasmodial properties.
The results of the in vitro tests with plant extracts
against chloroquine resistant P. falciparum strain (Dd2)
are presented in Table 2. Data on P. falciparum 3D7-
culture line is not included due to similarity of results.
The extracts of A. humilis (EA), C. odorata (DM), C.
laevigatum (DM) and C. bidentata (DM) showed
moderate antiplasmodial activity with IC50 values 5/
50 mg/ml. Six other medicinal plant extracts had evident
antiplasmodial activity against chloroquine resistant P.
falciparum , with IC50 values 5/10 mg/ml: S. spargano-
phorum (PE), V. amygdalinab (EA), Cinchona succirubra
(CEE and all fractions), T. diversifolia (PE, DM), P.
angolensis (CEE) and M. lucida (CEE). Comparing with
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the IC50 value obtained for Artemisia annua (3.9 mg/ml)
and for Azadirachta indica (10 mg/ml) this group of
plants has promising results (Phillipson et al., 1987).
Nevertheless, plants that are frequently reported as used
as antimalarials in various countries do not necessarily
show high activity in the in vitro test. These findings can
probably partly be explained because many of the plants
used in the treatment of malaria could have other
therapeutic activities either than antiparasitic effect,
such as antipyretic or immunomodulatory.
In two of the studied medicinal plants (P. angolensis
and M. lucida) the crude extracts showed marked
antiplasmodial activities but the fractions were all
much less active. A simple explanation could be due to
possible synergisms between the complex and hetero-
geneous mixture of different compounds in the crude
extracts that are lost during fractionation. Other possi-
bility is the instability of the fractionated and/or purified
molecules, which are otherwise protected by chlorophyll
and/or other components (Zani et al., 1997).
In the cytotoxicity and exoerythrocytic antimalarial
activity of plant extracts against P. berghei in vitro (Hep
G2 cells) (Table 3), eleven of the tested extracts and
fractions revealed hepatic schizontocidal activity, in
concentrations below the respective MLD values (S.
sparganophorum crude extract and methanol/water frac-
tion, A. humilis EA fraction, T. diversifolia PE and EA
fractions, C. odorata crude extract, P. angolensis PE and
EA fractions, M. lucida bark crude extract and PE
fraction and M. lucida leaves PE fraction). From these,
Table 3
Cytotoxicity and exoerythrocytic antimalarial activity of plant extracts against Plasmodium berghei in vitro (Hep G2 cells)
Extract number Plant species Cytotoxicity MLD (mg/ml) Tested doses (mg/ml) Schizontocide activity IC50 (mg/ml)
1 Struchium sparganophorum 50 50/25 24
1PE Struchium sparganophorum 100 100/50 n.d.
1DM Struchium sparganophorum 25 25/10 35
1EA Struchium sparganophorum 50 50/25 78
1MW Struchium sparganophorum 500 500/250 482
2 Vernonia amygdalina 250 250/100 n.a.
3 Vernonia amygdalina b 250 250/100 305
4 Ageratum conyzoides 100 100/50 135
5 Cinchona succirubra 250 250/100 n.a.
6 Aloe humilis 500 500/250 n.a.
6PE Aloe humilis 100 100/50 n.a.
6DM Aloe humilis 10 10/1 19
6EA Aloe humilis 500 500/250 354
6MW Aloe humilis 100 100/50 344
7 Tithonia diversifolia 100 100/50 287
7PE Tithonia diversifolia 50 50/25 18
7DM Tithonia diversifolia 10 10/1 n.a.
7EA Tithonia diversifolia 250 250/100 117
7MW Tithonia diversifolia 500 500/250 n.a.
8 Cedrela odorata 250 250/100 158
9 Premna angolensis 500 500/250 n.a.
10 Pycnanthus angolensis 250 250/100 n.a.
10PE Pycnanthus angolensis 100 100/50 34
10DM Pycnanthus angolensis 500 500/250 n.a.
10EA Pycnanthus angolensis 25 25/10 22
11a Morinda lucida (bark ) 500 500/250 415
11aPE Morinda lucida (bark ) 10 10/1 5
11aDM Morinda lucida (bark ) 10 10/1 n.d.
11aEA Morinda lucida (bark ) 50 50/25 137
11aMW Morinda lucida (bark ) 500 500/250 n.a.
11b Morinda lucida (leaves ) 50 50/25 76
11bPE Morinda lucida (leaves ) 250 250/100 103
11bDM Morinda lucida (leaves ) 100 100/50 167
11bEA Morinda lucida (leaves ) 500 500/250 n.a.
12 Cestrum laevigatum 250 250/100 n.a.
13 Canna bidentata 500 500/250 n.a.
MLD (minimal lethal dose)*/dose that inhibits 30% of cell growth; CEE, crude ethanolic extracts; PE, petroleum ether fraction; DM,
dichloromethane fraction; EA, ethyl acetate fraction; MW, remanescent methanol and water fraction; n.a., not active; n.d., not determined. IC50
(primaquine)0.003 mg/ml. MLD (primaquine)0.1 mg/ml.
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four plants revealed evident schizontocidal activity with
IC50 values from 5 to 34 mg/ml (S. sparganophorum , T.
diversifolia , P. angolensis and M. lucida bark).
The plant extracts and fractions that showed signifi-
cant activity in in vitro tests have been selected for in
vivo assays for antimalarial activity (S. spargano-
phorum , C. succirubra , T. diversifolia , C. odorata and
P. angolensis ). Such preliminary screening does not
preclude the possibility that the other extracts, not
assayed, may be active antimalarial agents by the oral
route. In general, the tested plant extracts were partly
active against the rodent malaria, except for Cinchona
extracts that showed a total chemosuppression of
parasitaemia in mice infected with P. berghei . However,
two of them, S. sparganophorum and C. odorata crude
extracts, exhibited a significant inhibition (PB/0.05) of
the parasite multiplication (85 and 73%, respectively), at
oral doses of 1000 mg/kg per day. The parasitaemia
(mean9/standard deviation) of the infected control
group at the end of the 4-day test was 10.349/2.11%;
for the mice treated with S. sparganophorum the
parasitaemia was 1.549/1.38% and for the mice treated
with C. odorata the parasitaemia was 2.849/0.99%.
The median time of mice survival of the infected
treated animals versus the control group (239/3 days)
was calculated and one plant extract increased this time
by 35% (C. odorata).
4. Conclusions
The resistance of P. falciparum to chloroquine is now
a major health problem in STP, as in many parts of
Africa, and these data suggest a potential role for
medicinal plant extracts in the treatment of chloro-
quine-resistant falciparum malaria.
Our study indicates that traditional healers in STP use
several medicinal plants against fever and/or malaria
which have demonstrated varying activity against blood
stage parasites of chloroquine resistant P. falciparum , as
well as against the hepatic development of P. berghei in
Hep G2 liver cells. The effectiveness against liver stage
development suggests that they could also be used as
preventive medicines. The development of phytophar-
maceutical products with these capacities could be of
relevance for the protection of risk groups, in areas with
such high levels of resistance.
Phytochemical studies of the four most active plants
(S. sparganophorum , T. diversifolia , P. angolensis and
M. lucida) are being performed, in order to identify the
most effective fraction or compound, bearing in mind
that the optimal product may not always correspond to
single compounds.
In order to develop more appropriate formulations
for local production and administration of these pro-
ducts, in collaboration with local traditional healers,
further studies (non-clinical toxicological studies, as well
as local clinical observations to confirm safety and
efficacy) are required.
This will have an obvious economic advantage for the
local populations, as the developed medicinal plant
products will be the cheapest therapeutic alternative
for malaria.
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